Inventor
WOLDEMUSSIE ELIZABETH
US19 patents
⚠️ This page may combine multiple inventors who share the name “WOLDEMUSSIE ELIZABETH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALLERGAN INC
11 patentsUS6465464B2Oct 15, 2002
Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
ALLERGAN INC72 citations95
US5925342AJul 20, 1999
Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
ALLERGAN INC90 citations95
US5573758ANov 12, 1996
Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
ALLERGAN INC52 citations93
US5856329AJan 5, 1999
Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
ALLERGAN INC50 citations92
US5716952AFeb 10, 1998
Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists
ALLERGAN INC49 citations92
US5705530AJan 6, 1998
Method for reducing intraocular pressure in the mammalian eye by administration of chloride channel blockers
ALLERGAN INC22 citations92
US5559151ASep 24, 1996
Method for reducing intraocular pressure in the mammalian eye by administration of chloride channel blockers
ALLERGAN INC20 citations92
US5891911AApr 6, 1999
Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators
ALLERGAN INC9 citations73
US5677327AOct 14, 1997
Method for identifying muscarinic agents lacking miotic side effects
ALLERGAN INC4 citations63
US5866605AFeb 2, 1999
Method for providing a neuroprotective effect to the mammalian eye by administration of chloride channel blockers
ALLERGAN INC2 citations62
US5521210AMay 28, 1996
Ophthalmic use of muscarinic agonists having increased duration of activity
ALLERGAN INC1 citations51
ALLERGAN SALES INC
6 patentsUS6248741B1Jun 19, 2001
Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
ALLERGAN SALES INC98 citations98
US6194415B1Feb 27, 2001
Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury
ALLERGAN SALES INC168 citations98
US6164282ADec 26, 2000
Methods for restoring and/or enhancing accommodation in pseudo phakia
ALLERGAN SALES INC106 citations97
US6410544B1Jun 25, 2002
Cholinergic agents in the treatment of presbyopia
ALLERGAN SALES INC74 citations96
US6291466B1Sep 18, 2001
Cholinergic agents in the treatment of presbyopia
ALLERGAN SALES INC62 citations96
US6077839AJun 20, 2000
Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (GABA) agonists
ALLERGAN SALES INC5 citations62